SEC Form 4 · accession 0001209191-17-015317
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yao Wenqing
Officer — EVP, Head of Discovery Chem
Period of report
Feb 14, 2017
Accepted (ET)
Feb 28, 2017 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 14, 2017 | A | 2,322 | $0.00 | A | 38,631 | D | |
| Common StockF3,F2 | Feb 24, 2017 | F | 788 | $121.95 | D | 37,843 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired upon vesting of performance shares. Each performance share represented the right to receive one or more shares of common stock based on, and subject to, the achievement of certain clinical and revenue milestones as set forth in the Performance Share Award Agreement. The number of shares of common stock that the Reporting Person was entitled to receive ranged from 0% to 125% of the number of performance shares awarded. Performance share milestones were achieved at the 100% level.
- F2Includes an aggregate of 21,380 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F3Represents shares withheld to satisfy tax withholding obligations with respect to vested performance shares.